
The current focus on drugs to prevent hip fractures is neither viable as a public health strategy nor cost effective, argue an international team of researchers.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/RqKP5713rrg/150526215025.htm
The current focus on drugs to prevent hip fractures is neither viable as a public health strategy nor cost effective, argue an international team of researchers.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/RqKP5713rrg/150526215025.htm